Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | -.--% |
|
-.--% | -.--% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Nutraceutical and Pharmaceutical Products
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 55 | 10/03/19 |
Mahmoud Aziz
CHM | Chairman | - | 18/05/21 |
Danny Lee
DFI | Director of Finance/CFO | - | 13/12/20 |
Kevin Bottomley
BRD | Director/Board Member | 45 | 04/09/19 |
Jamie Lewin
BRD | Director/Board Member | 74 | 10/03/19 |
Buckley Dodds
AUD | Comptroller/Controller/Auditor | - | 25/05/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Danny Lee
DFI | Director of Finance/CFO | - | 13/12/20 |
Jamie Lewin
BRD | Director/Board Member | 74 | 10/03/19 |
Mahmoud Aziz
CHM | Chairman | - | 18/05/21 |
Paul Chow
BRD | Director/Board Member | 59 | - |
Kevin Bottomley
BRD | Director/Board Member | 45 | 04/09/19 |
Sina Pirooz
CEO | Chief Executive Officer | 55 | 10/03/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,224,131 | 33,550,348 ( 56.65 %) | 0 | 56.65 % |
Company contact information
Genix Pharmaceuticals Corp.
1055 West Hastings Street Suite 300
V6E 2E9, Vancouver
+604-609-6198
http://www.genixpharm.com![address Genix Pharmaceuticals Corporation(GENX)](https://cdn.zonebourse.com/static/address/60342547.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.27% | 8.27B | |
+3.37% | 7.47B | |
-11.26% | 5.23B | |
-8.69% | 3.62B | |
-18.20% | 3.26B | |
-11.27% | 1.22B | |
-30.34% | 1.06B | |
-10.34% | 861M | |
-16.06% | 857M |
- Stock Market
- Equities
- GENX Stock
- GENX Stock
- Company Genix Pharmaceuticals Corporation